Filing Flows

Filing Flows › Technology › Hinge Health (HNGE)

Hinge Health (HNGE) earnings and revenue breakdown

Latest: Q3 2026 · 8-K filed Nov 2, 2026

Q3 2026 Revenue up 52% year over year to $235M · 24¢ of every $1 of revenue kept as net profit · operating margin 21.4%

Hinge Health made $235M in Q3 2026 (+52% Y/Y). Operating margin 21.4%, net earnings $57.4M. See where every dollar goes — costs, profit and cash — as a Sankey from the 8-K filed Nov 2, 2026 (preliminary, from the earnings release).

Revenue$235M
Year over year+52%
Operating margin21.4%
Net earnings$57.4M
Operating cash flow$115M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $235.0M in Q3 2026, up 52% year over year and up 10% from the previous quarter.

Gross margin was 87.0%, up 5.1 points from Q3 2025. Operating profit was $50.3M, a 21.4% margin (up 25.4 points year over year). Operating expenses grew 16% against revenue growth of 52%. The fastest-growing cost line was Sales & marketing (+34%). Net earnings were $57.4M. The effective tax rate was -6.9%.

Operating cash flow was $114.6M (up 39% year over year), 200% of net earnings. Non-cash charges added back $2.2M of depreciation and amortization and $19.5M of share-based compensation. Working capital and other items added $35.4M. After purchases of property, equipment and software (including capitalized internal use software) ($1.9M), free cash flow as the company reports it was $112.7M.

Quarterly history

Hinge Health revenue by quarterHinge Health revenue by quarter$139MQ2 2025$154MQ3 2025$171MQ4 2025$182MQ1 2026$213MQ2 2026$235MQ3 2026
Hinge Health net earnings by quarterHinge Health net earnings by quarter−$576MQ2 2025−$1.8MQ3 2025$32.1MQ4 2025$35.1MQ1 2026$43.7MQ2 2026$57.4MQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 20268-KNov 2, 2026$235M+52%21.4%$57.4M$115M
Q2 202610-QAug 6, 2026$213M+53%19.0%$43.7M$101M
Q1 202610-QMay 7, 2026$182M+47%17.6%$35.1M$43.1M
Q4 202510-KMar 3, 2026$171M+46%16.0%$32.1M$63.9M
Q3 202510-QNov 7, 2025$154M+53%-4.0%−$1.8M$82.4M
Q2 202510-QAug 11, 2025$139M+55%-417.5%−$576M$20.2M

Charts

Hinge Health: revenue growth, year over year and quarter over quarterHinge Health: revenue growth, year over year and quarter over quarterY/YQ/Q+55%Q2 2025+53%+11%Q3 2025+46%+11%Q4 2025+47%+7%Q1 2026+53%+17%Q2 2026+52%+10%Q3 2026
Latest (Q3 2026): Y/Y +52%, Q/Q +10%.
Hinge Health: where the cash came from (+) and went (−), TTM to Q2 2026Hinge Health: where the cash came from (+) and went (−), TTM to Q2 2026Operating cash flow$291MBuybacks−$197MCash drawn (+) / kept (−)−$48.7MTaxes on employees’ shares−$42.8MOther investing−$19.1MShares issued$17.2MCapital spending−$666KOther financing−$288K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Hinge Health: profit against cash, quarter by quarterHinge Health: profit against cash, quarter by quarterNet incomeOperating cash flow$341K$28.4MQ3 2024$27.1M$38.3MQ4 2024$17.1M$4.9MQ1 2025−$576M$20.2MQ2 2025−$1.8M$82.4MQ3 2025$32.1M$63.9MQ4 2025$35.1M$43.1MQ1 2026$43.7M$101MQ2 2026
Latest (Q2 2026): Net income $43.7M, Operating cash flow $101M.
Hinge Health: diluted shares by fiscal year (split-adjusted)Hinge Health: diluted shares by fiscal year (split-adjusted)52MFY202354MFY202455MFY2025
+4.8% since FY2023: more shares outstanding (issuance, stock pay); earlier years scaled for the 4-for-1 split before FY2025.
Hinge Health in its industry: growth against margin (65 companies, SIC 7374)Hinge Health in its industry: growth against margin (65 companies, SIC 7374)revenue growth, year over year →↑ operating marginmedian +9%median -8%ADPDXCWDAYTOSTRDDTVRSKRNGPLTKCLVTFAPEGAAPLDFIVNTASKEVTCCARGNRDSLFTORAMPGDRXLZEGHTUPWKCARSIBEXSSTKLIFYEXTTCXINODOOMAHAWKGLOOBRUNFIRYVERIBIRDINFQNXTTQMLSTRAKMOVEQBTSSHAZDTCXSDCHONFOBHICKWIKSEQCPHUNWORXONEICASTDTSTHTCRPWDYPVITMYX Inc.NTCSSTWIRADCCRCWHNITHNGE (+52%, 21%)
Services-Computer Processing & Data Preparation; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

Customers and suppliers named in filings

Sells to

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients and members. We have designed our platform to address a broad spectrum of MSK care—from acute injury, to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through our AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device, all designed and monitored by our AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches.

In its own words, from its 10-K, filed Mar 3, 2026.

Hinge Health against its Services-Computer Processing & Data Preparation peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +52% against the peers' median +6%. Operating margin: 21.4% against the peers' median 17.2%.

CompanyQuarterRevenueY/YOp. margin
HNGE Hinge HealthQ3 2026$235M+52%21.4%
ADP Automatic Data ProcessingQ1 FY27$5.5B+6%23.9%
DXC DXC TechnologyQ2 FY27$3.0B-4%6.2%
WDAY WorkdayQ2 FY27$2.6B+13%11.8%
TOST ToastQ3 2026$2.0B+21%8.3%
RDDT RedditQ3 2026$895M+53%29.2%
VRSK Verisk AnalyticsQ3 2026$809M+5%45.2%
RNG RingCentralQ3 2026$676M+6%8.0%
PLTK Playtika HoldingQ3 2026$674M-0.1%17.2%

Source: Hinge Health 8-K on SEC EDGAR · CIK 1673743 · Services-Computer Processing & Data Preparation

Guidance and outlook

Hinge Health Revenue: guidance against what was reportedHinge Health Revenue: guidance against what was reportedguided rangereported (above / within / below)Q3 2025$154MFY2025$588MQ4 2025$171MFY2026
Met or beat 3 of 3 guided periods. Grey: the last range guided before the figures came out; dot: the reported figure.

13F: who owns HNGE and who is buying

Largest holders of HNGE (13F)Largest holders of HNGE (13F)BlackRock$296M11.2 Capital Management, LLC$205MAssenagon Asset Management S.A.$180MVanguard Portfolio Management LLC$178MDeer Management Co. LLC$158MVanguard Capital Management LLC$157MTwo Sigma Investments, LP$150MFuller & Thaler Asset Management$142MMorgan Stanley$134MFranklin Resources$131M
Funds' net buying of HNGE by quarter (13F)Funds' net buying of HNGE by quarter (13F)$1.7B2025-06$14.0M2025-09$127M2025-12$200M2026-03$150M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on HNGE

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results

Compare HNGE with

中文版:Hinge Health(HNGE)财报

Español · Français